• Sulfo-NHS-Biotin: Reliable Cell Surface Labeling for Researc

  2026-06-22

  This authoritative article examines how Sulfo-NHS-Biotin (SKU A8001) from APExBIO addresses core laboratory challenges in cell viability, proliferation, and cytotoxicity assays. Integrating data-backed protocol insights, vendor comparisons, and practical troubleshooting, we demonstrate why Sulfo-NHS-Biotin is the reagent of choice for reproducible, high-fidelity cell surface protein labeling and downstream affinity workflows.

• Radioiodinated Balsalazide as a Selective Ulcerative Colitis

  2026-06-21

  The referenced study developed and characterized a radioiodinated form of balsalazide as a highly selective radiotracer for imaging ulcerative colitis (UC) in mouse models. This innovation leverages targeted colonic uptake and high labeling stability, offering new capabilities for preclinical imaging and mechanistic investigation of UC.

• Dihydrotestosterone (DHT): Driving Translational Androgen Re

  2026-06-20

  Explore how Dihydrotestosterone (DHT) empowers translational research in androgen signaling, cancer biology, and neurodegeneration. This thought-leadership article integrates mechanistic insights, competitive landscape analysis, and practical guidance, positioning APExBIO's DHT as a precision tool for innovative discovery.

• EZ Cap EGFP mRNA 5-moUTP: Precision mRNA Delivery & Imaging

  2026-06-19

  EZ Cap™ EGFP mRNA (5-moUTP) empowers researchers with robust, low-immunogenicity expression of enhanced green fluorescent protein for gene regulation, in vivo imaging, and translation efficiency assays. Leverage cutting-edge chemical modifications and workflow innovations to surpass traditional mRNA reporters, with built-in strategies for troubleshooting and scaling applications beyond the liver. Discover how APExBIO's engineering sets a new standard in reproducible, high-sensitivity mRNA delivery.

• LGK-974: PORCN Inhibitor Workflows for Wnt-Driven Cancer Mod

  2026-06-19

  LGK-974 empowers researchers to precisely dissect Wnt signaling in cancer and developmental biology, combining nanomolar potency with a proven record in RNF43-mutant pancreatic cancer and xenograft models. This article translates the latest reference findings into actionable protocols and troubleshooting strategies for reproducible, high-impact results.

• 5-Methyl-CTP: Advancing mRNA Synthesis with Enhanced Stabili

  2026-06-18

  5-Methyl-CTP empowers researchers to synthesize highly stable, translationally efficient mRNA, directly impacting vaccine and therapeutic development. Learn how to optimize your in vitro transcription workflow and troubleshoot common pain points for robust, reproducible mRNA outputs.

• D-Luciferin: Illuminating Metastasis Mechanisms in Translati

  2026-06-18

  This thought-leadership article explores how D-Luciferin—a high-affinity firefly luciferase substrate—empowers translational researchers to quantify metastatic signaling and tumor burden non-invasively. Integrating mechanistic insights from recent colorectal cancer studies, the discussion bridges advanced bioluminescence imaging with clinical strategy, offering protocol guidance and a forward-looking perspective on translational impact.

• Pioglitazone as a PPARγ Agonist: Mechanistic Leverage for Tr

  2026-06-17

  This article provides translational researchers with a mechanistically rigorous, strategically actionable guide to the use of pioglitazone—a selective PPARγ agonist—as a research tool across metabolic, inflammatory, and neurodegenerative disease models. Integrating new evidence on STAT-1/STAT-6 signaling and macrophage polarization, it bridges the gap between basic discovery and advanced translational workflows, highlighting best practices and workflow innovations for maximizing experimental impact.

• Live-Dead Cell Staining Kit I: Optimizing Mammalian Cell Via

  2026-06-17

  The Live-Dead Cell Staining Kit I (Calcein AM/PI) from APExBIO empowers precise, dual-fluorescent detection of cell viability and cytotoxicity in mammalian models. This guide delivers advanced workflow strategies, experimental tips, and troubleshooting grounded in recent oncology and regenerative research.

• A23187, Free Acid: Precision Calcium Ionophore Mechanisms

  2026-06-16

  A23187, free acid is a well-validated calcium ionophore that increases intracellular Ca2+ and enables controlled induction of apoptosis, phosphoinositide hydrolysis, and contractility modulation. Its robust, concentration-dependent actions are supported by peer-reviewed studies and standardized product characterization. APExBIO provides A23187, free acid (SKU: B6646) for research use with detailed stability and application guidelines.

• Apicidin (SKU A8176): Reliable HDAC Inhibition for Cell Assa

  2026-06-16

  This article addresses practical challenges faced in cell-based assays, highlighting how Apicidin (SKU A8176) from APExBIO delivers consistent, data-backed results for epigenetics and cytotoxicity workflows. Scenario-driven Q&As bridge real lab issues with validated protocol insights, optimizing both experiment reproducibility and interpretability.

• Sulfo-NHS-SS-Biotin Kit: Precision, Reversible Protein Label

  2026-06-15

  The Sulfo-NHS-SS-Biotin Kit enables highly selective, reversible biotinylation of cell surface proteins and antibodies. Its water-soluble, amine-reactive chemistry facilitates efficient labeling and purification, while the disulfide bond allows controlled cleavage. The kit, distributed by APExBIO, is validated for advanced interactome mapping and cell surface profiling.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-06-15

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and autologous stromal cell subpopulations, more accurately reflecting the tumor microenvironment. The system reveals how stromal diversity modulates gene expression and drug responsiveness, advancing the development of personalized therapeutic strategies.

• PAD4-IN-2 TFA: Precision PAD4 Inhibition and Tumor Microenvi

  2026-06-14

  Explore how PAD4-IN-2 TFA, a meta-phenylboronic acid-modified PAD4 inhibitor, enables highly selective tumor targeting by modulating the PAD4-H3cit-NETs pathway. This article reveals unique insights into immune microenvironment reshaping and practical assay implications, setting it apart from prior reviews.

• Imaging Neuroinflammation in Chronic Hepatic Encephalopathy:

  2026-06-13

  This study harnesses [18F]PBR146 PET imaging to compare the impact of Bifidobacterium and fecal microbiota transplantation (FMT) on neuroinflammation in a rat model of chronic hepatic encephalopathy. The results reveal Bifidobacterium's efficacy in inhibiting neuroinflammation, while FMT did not yield positive effects—insights that refine our understanding of gut–liver–brain interactions and inform future experimental design.

554 records 14/37 page Previous Next First page 上5页 1112131415 下5页 Last page